Project on Government Oversight, March 19, 2021: The Project on Government Oversight’s new report about the Pfizer COVID Vaccine raises questions about why the FDA did not publicly disclose quality control concerns that were publicly raised in Europe. We ask: Is “adequate” quality control good enough?
Read More »Tag: Pfizer
A C.D.C. analysis describes anaphylaxis after people have received the Pfizer-BioNTech vaccine as ‘rare’
NYT, January 9, 2021. Federal health officials say allergic reactions to coronavirus vaccines are rare, but serious, and every site administration vaccines must be prepared to recognize and treat them.
Read More »